← Leaderboards
Daniel Paul Wermeling
Antiop, Inc.
$3,450,564
Attributed
$3,450,564
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2010–14$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,450,564 · 1
By mechanism
R42$3,450,564 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Meetings”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$566,636,343
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$296,614,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$204,659,093
- Peter B. Gilbert · Fred Hutchinson Cancer Center$167,167,617
Research focus
MeetingsNoseInjection Of Therapeutic AgentMedicalNaloxoneNeedlestick InjuriesHeroinHuman ResourcesEmergency Medical ServiceIntramuscular InjectionsHepatitisMorphineClinical ResearchNeedlesBaseDrug KineticsBiological AvailabilityDrug FormulationsDesignBiopharmaceuticsIntramuscularDoseAntidotesNovel Therapeutics
Grant awards (5)
Naloxone Nasal Spray Development$995,554
R42 · FY2014 · DA · contact PI
Naloxone Nasal Spray Development$1,000,000
R42 · FY2013 · DA · contact PI
Intranasal Naloxone: An Opioid Overdose Antidote$239,195
R42 · FY2012 · DA · contact PI
Intranasal Naloxone: An Opioid Overdose Antidote$975,907
R42 · FY2011 · DA · contact PI
Intranasal Naloxone: An Opioid Overdose Antidote$239,908
R42 · FY2010 · DA · contact PI